Literature DB >> 23090573

Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Allison B Weisbrod1, Richard C Webb, Aarti Mathur, Stephanie Barak, Smita Baid Abraham, Naris Nilubol, Martha Quezado, Constantine A Stratakis, Electron Kebebew.   

Abstract

BACKGROUND: Primary hyperaldosteronism is most commonly due to a solitary cortical adenoma. Thus, some surgeons have suggested a subtotal adrenalectomy is a reasonable approach when a mass can be identified. On the other hand, adrenal vein sampling (AVS) is being used more frequently to distinguish patients with unilateral disease for adrenalectomy, even if a discrete mass is not identified on axial imaging. In these cases, surgical pathology may reveal a cortical adenoma, a cortical adenoma with hyperplasia, or cortical hyperplasia. The goal of this study was to compare the presentation and outcome among patients undergoing adrenalectomy and found to have different histologic features.
METHODS: We performed a retrospective analysis of 136 patients with primary hyperaldosteronism. A total of 95 patients had an adrenalectomy for unilateral disease. The preoperative clinical and laboratory, and postoperative outcome of the three aforementioned histologic groups were compared.
RESULTS: A total of 95 patients underwent an adrenalectomy. We found no significant difference in age, gender, body mass index, duration of hypertension, number of antihypertensive medications, serum aldosterone level, serum renin level, or adrenal vein sampling ratios among the three histologic categories. We also found no significant difference among the three categories in postoperative cure rate.
CONCLUSION: The rate of unilateral hyperplasia in patients with primary hyperaldosteronism (16%) is likely higher than previously reported, which may be due to the increasing use of AVS. The clinical presentation and outcome of patients regardless of the histologic findings are similar. Our data also suggests that subtotal adrenalectomy would not be appropriate in patients with primary hyperaldosteronism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090573      PMCID: PMC3556341          DOI: 10.1245/s10434-012-2670-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  46 in total

1.  Primary aldosteronism: a new clinical entity.

Authors:  J W CONN; L H LOUIS
Journal:  Trans Assoc Am Physicians       Date:  1955

2.  Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.

Authors:  L G Chen; T I Lee; H D Lin; H C Wang; W Y Liu; K T Tang
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1997-02

3.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

4.  A case of primary aldosteronism due to unilateral adrenal hyperplasia.

Authors:  Yasuyuki Katayama; Nobuki Takata; Taiji Tamura; Akemi Yamamoto; Fumihiko Hirata; Hiroko Yasuda; Susumu Matsukuma; Yuichiro Daido; Hironobu Sasano
Journal:  Hypertens Res       Date:  2005-04       Impact factor: 3.872

5.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

6.  Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.

Authors:  Gary L Schwartz; Stephen T Turner
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

7.  A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules.

Authors:  Yuki Hirono; Masaru Doi; Takanobu Yoshimoto; Kazuo Kanno; Yoshiro Himeno; Kazuhiro Taki; Hironobu Sasano; Yukio Hirata
Journal:  Endocr J       Date:  2005-08       Impact factor: 2.349

8.  Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I.

Authors:  Michael Stowasser; James Sharman; Rodel Leano; Richard D Gordon; Gregory Ward; Diane Cowley; Thomas H Marwick
Journal:  J Clin Endocrinol Metab       Date:  2005-06-07       Impact factor: 5.958

9.  Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.

Authors:  F Otsuka; F Otsuka-Misunaga; S Koyama; H Yamanari; T Ogura; T Ohe; H Makino
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

10.  Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.

Authors:  Franco Lumachi; Mario Ermani; Stefano M M Basso; Decio Armanini; Maurizio Iacobone; Gennaro Favia
Journal:  Am Surg       Date:  2005-10       Impact factor: 0.688

View more
  6 in total

Review 1.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

2.  Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?

Authors:  Omair A Shariq; Kabir Mehta; Geoffrey B Thompson; Melanie L Lyden; David R Farley; Irina Bancos; Benzon M Dy; William F Young; Travis J McKenzie
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

4.  Partial versus total adrenalectomy for the treatment of unilateral aldosterone-producing adenoma: a systematic review and meta-analysis.

Authors:  Kun-Peng Li; Xi Duan; Xue-Song Yang; Jing Huang; Tao Wu
Journal:  Updates Surg       Date:  2021-06-19

5.  Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism.

Authors:  Jing Xie; Cui Zhang; Xuefeng Wang; Yiran Jiang; Luming Wu; Lei Ye; Xuan Wang; Wen Xie; Haimin Xu; Weiqing Wang
Journal:  Front Med (Lausanne)       Date:  2022-04-12

Review 6.  Management of primary aldosteronism in patients with adrenal hemorrhage following adrenal vein sampling: A brief review with illustrative cases.

Authors:  Fady Hannah-Shmouni; Andrew Demidowich; Beatriz Rizkallah Alves; Gabriela Dockhorn Paluch; Dionysiou Margarita; Charalampos Lysikatos; Elena Belyavskaya; Richard Chang; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-09       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.